Ensysce Biosciences, Inc. Profile Avatar - Palmy Investing

Ensysce Biosciences, Inc.

Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It develops products using Trypsin Activate…

Biotechnology
US, La Jolla [HQ]

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of ENSC's Analysis
CIK: - CUSIP: 293602108 ISIN: US2936024056 LEI: - UEI: -
Secondary Listings
ENSC has no secondary listings inside our databases.